Revenue and earnings beat Street estimatesStrongest revenue growth in two yearsFirst ever dividend announcedShares in Alphabet (GOOG:NASDAQ) are set to open at a new all-time high after the Google parent reported strong double-digit first quarter revenue growth, and bested Wall Street profit estimates. The internet search giant also announced it would pay its first ever dividend.Pre-market data ha

London?s FTSE 100 pushed higher on Thursday, leaving peers on the continent and beyond in its wake, on share price rises for heavyweights AstraZeneca, Barclays and Unilever, as well as M&A impetus for Anglo American.Trade was underwhelming elsewhere, however, as equities struggled following a red-hot US inflation reading, which was coupled with numbers showing a slowdown in growth.The FTSE 100 ind

Second-quarter guidance disappointsAI spending plans spook investors$200 billion wiped off market valueSocial media and technology outfit Meta Platforms (META:NASDAQ) saw its recent share price momentum stall in a big way overnight as investors fretted its ?year of efficiency? in 2023 would give way to a period or profligacy.At one point more than $200 billion had been wiped off the company?s valu

First quarter sales and profit beat expectationsStrategy update scheduled for 21 MayFull year outlook confirmedShares in AstraZeneca (AZN) surged 5% to £119.3 closing in on a new 52-week high after first quarter revenue and earnings eclipsed market expectations and the pharmaceutical company reiterated full year guidance.After a few months of consolidation, the shares are back to winning ways and

Net interest income fallsInvestment bank slipsBuyback target confirmedHigh-street lender Barclays (BARC) reported a drop in first-quarter pre-tax profit due to a combination of weaker net interest income and lower income from its investment bank, but the results were slightly ahead of market expectations.The shares gained as much as 9p or 4.5% to 200p, their highest level in over a year, as the fi

Investors in London bought at the open on Thursday, looking ahead to US GDP data this afternoon, while Anglo American shares jumped after it confirmed that it was ?reviewing? a takeover bid from its larger Australian rival BHP Group.The FTSE 100 index opened up 33.81 points, 0.4%, at 8,074.19. The FTSE 250 was down 98.85 points, 0.5%, at 19,620.52, and the AIM All-Share was down 0.60 of a point, 0

Interest rates are expected to stay higher for longer to combat the sticky inflation which remains a threat to investors? hard-earned wealth and purchasing power. During periods of high inflation, it is crucial to invest in companies that possess pricing power, because these firms can pass on increased costs to customers, enabling them to maintain profit margins and generate the robust cash flows

A key rationale for investing in the smallest companies on the UK market is that these businesses have the most capacity for growth.However, for several reasons investing in micro-cap businesses is not for everyone and has, with some notable exceptions, proved less than fruitful in recent years. WHAT IS A MICRO CAP?The definition of what constitutes a micro cap varies. Natalie Bell, fund manager a

Xtrackers IE Physical Gold ETC Securities (XGDU) $35.61Assets: £2.43 billionIt may have beaten a hasty retreat from recent record highs as concerns about an escalating conflict in the Middle East have eased but gold prices are still forecast in many quarters to make further gains from here.For investors concerned about geopolitical and economic risk, as inflation shows signs of being more entrenc

Dr. Martens (DOCS) 72.1pLoss to date: 21.6%In mid-December 2023 we said the knock-down share price of iconic footwear brand Dr. Martens (DOCS) was too tempting to resist despite the company delivering four profit warnings.Our rationale was simple ? either the self-inflicted operational issues would be fixed by the current management or the business would be taken over by an opportunistic predator

This feature explores spin-offs or de-mergers, looking at the rationale for them and how they have performed, and asks if they can be a promising hunting ground for investors.One of the UK?s largest recent spin-offs was GSK?s (GSK) demerger of its consumer healthcare division in 2022.GSK reportedly rebuffed a £50 billion offer from personal goods giant Unilever (ULVR) to buy the division, named H

Stocks in London ended in the red on Wednesday, despite the FTSE 100 hitting another record high earlier in the day, while Tesla was the star in New York, where wider markets mixed.The FTSE 100 index gave back 4.43 points, 0.1%, at 8,040.38. The blue-chip index traded as high as 8,092.19 earlier Wednesday, its best-ever level. Selling pressure in the afternoon prevented it from achieving another c

Net interest income fallsCost-to-income ratio jumpsFull-year guidance maintainedThe UK?s largest mortgage lender, Lloyds Banking Group (LLOY), delivered a weak first-quarter trading update with most of the key metrics seemingly heading in the wrong direction.The lack of mention of share buybacks or guidance on the dividend also disappointed investors, however confirmation of the bank?s full-year t

Stock prices in London were up heading into the afternoon on Wednesday, with Reckitt jumping on a strong start to 2024, while Lloyds rose despite a fall in profit.The FTSE 100 index was up 38.40 points, 0.5%, at 8,083.21. The FTSE 250 was down 3.41 points at 19,796.31, and the AIM All-Share was up 0.1 of a point at 754.97.The Cboe UK 100 was up 0.5% at 807.00, the Cboe UK 250 was down 0.2% at 17,1

Investors in London continued to show confidence heading into the afternoon on Wednesday, looking ahead to key US data on Thursday and Friday.The FTSE 100 index opened up 27.80 points, 0.4%, at 8,072.61. The FTSE 250 was down 2.65 points at 19,797.07, and the AIM All-Share was up 1.63 points, 0.2%, at 756.50.The Cboe UK 100 was up 0.3% at 806.01, the Cboe UK 250 was down 0.1% at 17147.76, and the

The FTSE 100 hit an all-time high on Tuesday, before returning some gains after somewhat hawkish words from a UK monetary policymaker.The FTSE 100 index closed up 20.94 points, 0.2%, at 8,044.81. The FTSE 250 shot up 200.33 points, 1.0%, at 19,799.72, and the AIM All-Share ended up 5.69 points, 0.8%, at 754.87.The Cboe UK 100 ended up 0.2% at 803.32, the Cboe UK 250 rose 0.9% to 17,156.66, and the

Stock prices in London rose on Tuesday heading into the afternoon, as UK economic data buoyed investors with ?fresh optimism? and helped the FTSE 100 hit another intraday high.Amongst individual stocks, AB Foods was the star of the morning, thanks to a jump in its interim profit. JD Sports also rose, after agreed to buy US sports fashion retailer Hibbett for just over $1 billion.The FTSE 100 index

Deal priced at 21% premiumPurchase is earnings-accretiveUS now 40% of group revenueJD Sports Fashion (JD.) was one of the top gainers in the FTSE, gaining 7% to 126.1p as investors sensed a win-win outcome following the acquisition of US rival Hibbett (HIBB:NASDAQ) for $1.1 billion (£899 million) in cash.The proposed transaction values Hibbett at $87.5 per share, equating to a 21% premium to its

Margins beat across the boardInterim dividend raised sharplyFull-year outlook increasedGrocery-to-retail conglomerate Associated British Foods (ABF) delivered investors a double helping of good news with consensus-beating first-half results and a 46% increase in the interim dividend.In response the shares jumped 9% to £27.50, topping the FTSE 100 leader board and returning to their pre-pandemic p

Investors in London continued to show confidence, as stocks at the open on Tuesday added to Monday?s gains, boosted by the prospect of interest rate cuts.The FTSE 100 index opened up 33.06 points, 0.4%, at 8,056.93. The FTSE 250 was up 54.48 points, 0.3%, at 19,653.87, and the AIM All-Share was up 2.14 points, 0.3%, at 751.32.The Cboe UK 100 was up 0.3% at 804.24, the Cboe UK 250 was up 0.2% at 17